论文部分内容阅读
目的:对非破裂型输卵管妊娠治疗中采用中药联合米非司酮和甲氨蝶呤的临床疗效进行正确的评价,以推广更好的治疗方式。方法:从在我院妇产科进行治疗的非破裂型输卵管妊娠患者中选取83例作为研究对象,随机分成实验组和对照组,对照组仅采用米非司酮结合甲氨蝶呤治疗,实验组在对照组基础上联合中药治疗,对实验组和对照组的疗效进行对比。结果:实验组的治愈率明显高于对照组,两组比较差异显著,实验组血β-HCG下降至正常所耗时间和住院时间与对照组相比较,差异显著,p<0.05,具有统计学意义。结论:非破裂型输卵管妊娠医治过程中采用中药联合米非司酮和甲氨蝶呤的疗效明显且无副作用,建议将此种治疗方法推广使用。
OBJECTIVE: To evaluate the clinical efficacy of traditional Chinese medicine combined with mifepristone and methotrexate in the treatment of non-ruptured tubal pregnancy so as to promote a better treatment. Methods: 83 cases of non-ruptured tubal pregnancy treated in obstetrics and gynecology department of our hospital were selected as the research object and randomly divided into experimental group and control group. The control group received only mifepristone combined with methotrexate, Group based on the control group combined with traditional Chinese medicine treatment, the experimental group and control group were compared. Results: The cure rate of the experimental group was significantly higher than that of the control group, the difference was significant between the two groups, the difference between the experimental group and the control group was significant (P <0.05) significance. Conclusion: The efficacy of traditional Chinese medicine combined with mifepristone and methotrexate in the treatment of non-ruptured tubal pregnancy is obvious and no side effects, it is recommended to promote the use of this treatment.